Lamba JK, Meshinchi S. Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin. haematol [Internet]. 2021Nov.1 [cited 2024Apr.19];106(11):2796-8. Available from: https://haematologica.org/article/view/haematol.2021.279043